SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-037578
Filing Date
2024-03-22
Accepted
2024-03-22 08:00:20
Documents
13
Period of Report
2024-03-22
Items
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm249318d1_8k.htm   iXBRL 8-K 27094
  Complete submission text file 0001104659-24-037578.txt   198977

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA armp-20240322.xsd EX-101.SCH 3027
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE armp-20240322_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE armp-20240322_pre.xml EX-101.PRE 22367
16 EXTRACTED XBRL INSTANCE DOCUMENT tm249318d1_8k_htm.xml XML 3485
Mailing Address 5005 MCCONNELL AVE LOS ANGELES CA 90066
Business Address 5005 MCCONNELL AVE LOS ANGELES CA 90066 310-665-2928
Armata Pharmaceuticals, Inc. (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37544 | Film No.: 24773124
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)